A Prospective Observational Study for Evaluating CGVHD (GITMO-GVCrOSy)
A Prospective Observational Study for Evaluating Incidence, Severity and Outcomes of Chronic Graft-versus-Host Disease According to 2015 NIH Consensus Criteria
Sponsor: Gruppo Italiano Trapianto di Midollo Osseo
This observational or N/A phase trial investigates Chronic Graft-Versus-Host Disease and is currently completed. Gruppo Italiano Trapianto di Midollo Osseo leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2021 — Dec 2022 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
-
Sep 2018 — Dec 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gruppo Italiano Trapianto di Midollo Osseo
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Ancona, Italy , Bari, Italy , Bergamo, Italy , Bologna, Italy , Bolzano, Italy , Brescia, Italy , Catania, Italy , Cuneo, Italy , Florence, Italy and 15 more locations